KRM Ayurveda IPO Details
The key details of KRM Ayurveda’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹77.49 Cr |
| Price Range | ₹128 - ₹135 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 2,000 |
| Investment (cut-off price) | ₹2,70,000 |
| Pre IPO Promotor Holding | 92.16% |
| Post IPO Promotor Holding | 67.28% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
KRM Ayurveda IPO Timelines
The IPO process for KRM Ayurveda includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
21/01/2026
Start Date23/01/2026
End Date28/01/2026
Refund Initiation28/01/2026
Credit of Shares to Demat Ac29/01/2026
Listing DateKRM Ayurveda IPO Lot Size
The KRM Ayurveda IPO has a fixed lot size of 1,000 shares, at an upper price band of ₹135 per share. For retail investors, the minimum and maximum application is 2,000 shares (2 lots) amounting to ₹2,70,000. For Small HNI (S-HNI) investors, the minimum application is 3,000 shares (3 lots) worth ₹4,05,000, while the maximum is 7,000 shares (7 lots) amounting to ₹9,45,000. Big HNI (B-HNI) investors need to apply for at least 8,000 shares (8 lots), totaling ₹10,80,000.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2000 | ₹2,70,000 |
| Retail Maximum | 2 | 2000 | ₹2,70,000 |
| S-HNI Minimum | 3 | 3000 | ₹4,05,000 |
| S-HNI Maximum | 7 | 7000 | ₹9,45,000 |
| B-HNI Minimum | 8 | 8000 | ₹10,80,000 |
KRM Ayurveda IPO Subscription Status
The subscription status for KRM Ayurveda IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 63.31x | 135.37x | 54.21x | -- | 74.27x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹ | ₹ | ₹ | ₹ |
KRM Ayurveda IPO Company Financials
KRM Ayurveda reports robust performance in FY2025 with Total Income of ₹76.95 crores, managing expenses at ₹60.61 crores, and achieving a strong PAT (Profit After Tax) of ₹12.10 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2023 | ₹89.38 | ₹79.29 | ₹7.60 |
| FY 2024 | ₹67.57 | ₹62.85 | ₹3.41 |
| FY 2025 | ₹76.95 | ₹60.61 | ₹12.10 |
| FY 2026 (6 M) | ₹48.65 | ₹37.65 | ₹8.14 |
About Company
Incorporated on 3 September 2019, KRM Ayurveda Ltd. operates an integrated network of Ayurvedic hospitals and clinics across multiple cities in India and has established an international presence through telemedicine consultation and product sales. The organization is engaged in the manufacturing of Ayurvedic medicines, herbal and botanical remedies, health supplements, and wellness and skin care products. As of December 31, 2025, operations are supported by a workforce of 443 employees across various functional departments.
The healthcare network currently comprises six hospitals and five clinics, equipped with comprehensive infrastructure including inpatient beds, Panchakarma treatment units, herbal pharmacies, medicine preparation units, Ayurvedic diet kitchens, consultation chambers for Vaidyas, and dedicated yoga and meditation halls. Medical services include inpatient and outpatient care for chronic and lifestyle-related conditions, Panchakarma therapies, specialized clinics for orthopedics, skin and hair care, women’s wellness, and geriatric care, along with wellness programs focused on stress management, weight management, and preventive healthcare. Additional offerings include the sale of Ayurvedic medicines, personalized diet planning, lifestyle guidance, and yoga consultation.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2019 | Healthcare | Dr. Puneet Dhawan |
Know Before Investing
KRM Ayurveda IPO Strengths
- KRM Ayurveda operates 6 hospitals and 5 clinics specialising in treatments for kidney disorders, liver cirrhosis, diabetes, fatty liver, and arthritis, combining traditional therapies with modern delivery systems.
- 31 BAMS physicians and 59 certified therapists provide clinical credibility and treatment specialisation across Panchakarma, wellness packages, and chronic disease management.
- Rising consumer preference for natural treatments, AYUSH ministry support, and wellness tourism create favourable demand environment for branded Ayurvedic healthcare.
- Medicinal sales complement treatment revenues, providing multiple growth levers beyond pure service dependency.
KRM Ayurveda IPO Risks
- Significant therapist and clinical staff turnover disrupts service continuity and increases recruitment/training costs in labour-intensive Ayurvedic operations.
- Majority operations in Delhi-Haryana region expose business to localised competition, regulatory changes, and economic slowdowns affecting patient footfall.
- Despite profit growth, cash generation from operations remains weak, signalling working capital strain and potential liquidity pressure during expansion.
- Ayurvedic claims, manufacturing, and telemedicine face AYUSH/CDSCO oversight; any lapses could trigger penalties or service restrictions.
- Established players like Patanjali, Himalaya, Dabur, and regional clinics compete aggressively on pricing, branding, and distribution.
- New multi-storey facility success depends on patient adoption, technology integration, and doctor availability for virtual consultations.
Swot Analysis for KRM Ayurveda IPO
Strengths
Integrated Ayurvedic Ecosystem, Trusted Brand Loyalty, Digital Telemedicine Reach
Weaknesses
Leased Premises Dependence, Geographic Revenue Concentration, Raw Material Supply Chain
Opportunities
Ayurveda Market Boom, D2C Product Retail, Wellness Program Diversification
Threats
Intense Competition, Misinformation Risk, Economic Sensitivity
Company Details
KRM Ayurveda Ltd.
A-16 G T Karnal road, North West, Delhi, New Delhi, 110033
Phone: +91-9289101700
Email: compliance@krmayurveda.com
Website: https://www.krmayurvedaindia.com/
IPO Registar Details
Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
FAQs
The key objectives of KRM Ayurveda SME IPO are:
- Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
- Purchase of CRM Software and Hardware Infrastructure
- Human Resources
- Repayment/Prepayment of loan
- Working Capital Requirement
- General Corporate Purposes
NEXGEN Financial Solutions Pvt. Ltd. is the book-running lead managers for the KRM Ayurveda IPO.
KRM Ayurveda is positioned to benefit from rising health consciousness, chronic disease prevalence, and government support for AYUSH. Its integrated hospital, clinic, manufacturing, and telemedicine model enables diversified revenues, while expansion beyond Delhi Haryana and scalable wellness offerings can drive sustained growth if execution improves.
The issue price for the KRM Ayurveda IPO is set between ₹128 to ₹135 per share.
To invest in two lot of KRM Ayurveda IPO, you need ₹2,56,000 at the lower price band (₹128 per share) or ₹2,70,000 at the upper price band (₹135 per share) for a lot size of 2,000 shares.
KRM Ayurveda IPO shares are scheduled to be listed on the National Stock Exchange (NSE) on January 29, 2025.
Refund/unblocking of funds for KRM Ayurveda IPO will begin on January 28, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your KRM Ayurveda IPO shares on listing day (January 29, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.